Structure

Physi-Chem Properties

Molecular Weight:  578.16
Volume:  540.657
LogP:  2.395
LogD:  1.25
LogS:  -4.41
# Rotatable Bonds:  9
TPSA:  225.81
# H-Bond Aceptor:  14
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.147
Synthetic Accessibility Score:  4.288
Fsp3:  0.407
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  3
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.988
MDCK Permeability:  2.159287760150619e-05
Pgp-inhibitor:  0.217
Pgp-substrate:  0.709
Human Intestinal Absorption (HIA):  0.284
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.834

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.008
Plasma Protein Binding (PPB):  90.60099029541016%
Volume Distribution (VD):  0.703
Pgp-substrate:  13.26782512664795%

ADMET: Metabolism

CYP1A2-inhibitor:  0.067
CYP1A2-substrate:  0.086
CYP2C19-inhibitor:  0.022
CYP2C19-substrate:  0.055
CYP2C9-inhibitor:  0.597
CYP2C9-substrate:  0.287
CYP2D6-inhibitor:  0.24
CYP2D6-substrate:  0.137
CYP3A4-inhibitor:  0.139
CYP3A4-substrate:  0.029

ADMET: Excretion

Clearance (CL):  5.142
Half-life (T1/2):  0.92

ADMET: Toxicity

hERG Blockers:  0.394
Human Hepatotoxicity (H-HT):  0.143
Drug-inuced Liver Injury (DILI):  0.981
AMES Toxicity:  0.811
Rat Oral Acute Toxicity:  0.032
Maximum Recommended Daily Dose:  0.007
Skin Sensitization:  0.641
Carcinogencity:  0.063
Eye Corrosion:  0.003
Eye Irritation:  0.716
Respiratory Toxicity:  0.014

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC211532

Natural Product ID:  NPC211532
Common Name*:   Patuletin 7-O-(6''-Isovaleryl)Glucoside
IUPAC Name:   [(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-6-methoxy-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 3-methylbutanoate
Synonyms:  
Standard InCHIKey:  SOEZANHKTWLRIX-BAHLFPRBSA-N
Standard InCHI:  InChI=1S/C27H30O14/c1-10(2)6-17(30)38-9-16-19(31)22(34)24(36)27(41-16)40-15-8-14-18(21(33)26(15)37-3)20(32)23(35)25(39-14)11-4-5-12(28)13(29)7-11/h4-5,7-8,10,16,19,22,24,27-29,31,33-36H,6,9H2,1-3H3/t16-,19-,22+,24-,27-/m1/s1
SMILES:  CC(C)CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](Oc2cc3c(c(=O)c(c(c4ccc(c(c4)O)O)o3)O)c(c2OC)O)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL474868
PubChem CID:   10370955
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003533] Flavonoid-7-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40994 Inula britannica Species Asteraceae Eukaryota Flowers n.a. n.a. PMID[10650074]
NPO17782 Inula britannica Species Asteraceae Eukaryota flowers n.a. n.a. PMID[16643020]
NPO17782 Inula britannica Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO17782 Inula britannica Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO17782 Inula britannica Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO17782 Inula britannica Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO17782 Inula britannica Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens IC50 = 11.7 ug.mL-1 PMID[554296]
NPT1 Others Radical scavenging activity IC50 = 14.3 ug.mL-1 PMID[554296]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC211532 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC233994
0.9939 High Similarity NPC477848
0.9878 High Similarity NPC472385
0.9878 High Similarity NPC198324
0.9817 High Similarity NPC43211
0.9817 High Similarity NPC49344
0.9817 High Similarity NPC264735
0.9817 High Similarity NPC101191
0.9817 High Similarity NPC210094
0.9817 High Similarity NPC115760
0.9817 High Similarity NPC237435
0.9817 High Similarity NPC135277
0.9816 High Similarity NPC211594
0.9816 High Similarity NPC172807
0.9816 High Similarity NPC476405
0.9816 High Similarity NPC254540
0.9816 High Similarity NPC117260
0.9756 High Similarity NPC45522
0.9756 High Similarity NPC169977
0.9756 High Similarity NPC4390
0.9756 High Similarity NPC21666
0.9756 High Similarity NPC42773
0.9756 High Similarity NPC24043
0.9756 High Similarity NPC101026
0.9755 High Similarity NPC84265
0.9755 High Similarity NPC245014
0.9755 High Similarity NPC282987
0.9695 High Similarity NPC175107
0.9695 High Similarity NPC153755
0.9695 High Similarity NPC190003
0.9693 High Similarity NPC201292
0.9693 High Similarity NPC475942
0.9693 High Similarity NPC469931
0.9693 High Similarity NPC186807
0.9693 High Similarity NPC45638
0.9693 High Similarity NPC93337
0.9693 High Similarity NPC226294
0.9693 High Similarity NPC105025
0.9693 High Similarity NPC58053
0.9643 High Similarity NPC470447
0.9643 High Similarity NPC470445
0.9643 High Similarity NPC36138
0.9643 High Similarity NPC470446
0.9643 High Similarity NPC470449
0.9639 High Similarity NPC472384
0.9639 High Similarity NPC268533
0.9639 High Similarity NPC472382
0.9639 High Similarity NPC472380
0.9639 High Similarity NPC169733
0.9634 High Similarity NPC244776
0.9634 High Similarity NPC116864
0.9634 High Similarity NPC155763
0.9634 High Similarity NPC235260
0.9634 High Similarity NPC20505
0.9632 High Similarity NPC58716
0.9632 High Similarity NPC45618
0.9632 High Similarity NPC146792
0.9586 High Similarity NPC470451
0.9586 High Similarity NPC470416
0.9586 High Similarity NPC470455
0.9583 High Similarity NPC222674
0.9581 High Similarity NPC168584
0.9576 High Similarity NPC205076
0.9576 High Similarity NPC307518
0.9576 High Similarity NPC48773
0.9576 High Similarity NPC472386
0.9573 High Similarity NPC138927
0.9573 High Similarity NPC120099
0.9573 High Similarity NPC225434
0.9573 High Similarity NPC219904
0.9573 High Similarity NPC203050
0.9573 High Similarity NPC223747
0.9571 High Similarity NPC197285
0.9571 High Similarity NPC21100
0.9527 High Similarity NPC107987
0.9524 High Similarity NPC110941
0.9524 High Similarity NPC241423
0.9524 High Similarity NPC473682
0.9524 High Similarity NPC126784
0.9524 High Similarity NPC473571
0.9524 High Similarity NPC470444
0.9524 High Similarity NPC470443
0.9521 High Similarity NPC8573
0.9521 High Similarity NPC470949
0.9521 High Similarity NPC472991
0.9521 High Similarity NPC472992
0.9521 High Similarity NPC65563
0.9518 High Similarity NPC204693
0.9515 High Similarity NPC21190
0.9515 High Similarity NPC105511
0.9515 High Similarity NPC224462
0.9515 High Similarity NPC22195
0.9515 High Similarity NPC206123
0.9515 High Similarity NPC183357
0.9512 High Similarity NPC127546
0.9512 High Similarity NPC116745
0.9512 High Similarity NPC173637
0.9512 High Similarity NPC265530
0.9512 High Similarity NPC325555
0.9512 High Similarity NPC84362
0.9512 High Similarity NPC223424
0.9512 High Similarity NPC52550
0.9512 High Similarity NPC226304
0.9512 High Similarity NPC317489
0.9509 High Similarity NPC22832
0.9509 High Similarity NPC277205
0.9509 High Similarity NPC311830
0.9467 High Similarity NPC473071
0.9467 High Similarity NPC473073
0.9464 High Similarity NPC173837
0.9464 High Similarity NPC139571
0.9464 High Similarity NPC217520
0.9464 High Similarity NPC35167
0.9461 High Similarity NPC253685
0.9458 High Similarity NPC3583
0.9458 High Similarity NPC259152
0.9455 High Similarity NPC471457
0.9455 High Similarity NPC472381
0.9455 High Similarity NPC210042
0.9455 High Similarity NPC95855
0.9455 High Similarity NPC170675
0.9455 High Similarity NPC472383
0.9455 High Similarity NPC112755
0.9451 High Similarity NPC274618
0.9451 High Similarity NPC253662
0.9451 High Similarity NPC308404
0.9451 High Similarity NPC277174
0.9451 High Similarity NPC113968
0.9451 High Similarity NPC73855
0.9451 High Similarity NPC88789
0.9451 High Similarity NPC135599
0.9451 High Similarity NPC99957
0.9451 High Similarity NPC181616
0.9451 High Similarity NPC118284
0.9451 High Similarity NPC145038
0.9451 High Similarity NPC179950
0.9451 High Similarity NPC281131
0.9451 High Similarity NPC328940
0.9451 High Similarity NPC56077
0.9451 High Similarity NPC276222
0.9448 High Similarity NPC191306
0.9448 High Similarity NPC270335
0.9448 High Similarity NPC222936
0.9448 High Similarity NPC94777
0.9448 High Similarity NPC88023
0.9448 High Similarity NPC243930
0.9448 High Similarity NPC284960
0.9448 High Similarity NPC19709
0.9448 High Similarity NPC309025
0.9412 High Similarity NPC473072
0.9405 High Similarity NPC61904
0.9405 High Similarity NPC144097
0.9405 High Similarity NPC471669
0.9405 High Similarity NPC89127
0.9401 High Similarity NPC239549
0.9401 High Similarity NPC175230
0.9401 High Similarity NPC236191
0.9401 High Similarity NPC88560
0.9401 High Similarity NPC172033
0.9401 High Similarity NPC472993
0.9401 High Similarity NPC51774
0.9398 High Similarity NPC285197
0.9398 High Similarity NPC34287
0.9398 High Similarity NPC95866
0.9398 High Similarity NPC149011
0.9398 High Similarity NPC44558
0.9398 High Similarity NPC474434
0.9398 High Similarity NPC471416
0.9398 High Similarity NPC204937
0.9398 High Similarity NPC67105
0.9394 High Similarity NPC229729
0.9394 High Similarity NPC93099
0.9394 High Similarity NPC135345
0.939 High Similarity NPC55786
0.939 High Similarity NPC19388
0.939 High Similarity NPC240431
0.9387 High Similarity NPC473043
0.9387 High Similarity NPC77660
0.9387 High Similarity NPC189142
0.9357 High Similarity NPC148710
0.9349 High Similarity NPC476619
0.9349 High Similarity NPC267680
0.9349 High Similarity NPC476622
0.9349 High Similarity NPC113836
0.9349 High Similarity NPC476618
0.9349 High Similarity NPC217387
0.9349 High Similarity NPC476623
0.9349 High Similarity NPC37668
0.9349 High Similarity NPC477895
0.9349 High Similarity NPC476620
0.9349 High Similarity NPC253521
0.9349 High Similarity NPC196127
0.9349 High Similarity NPC258044
0.9349 High Similarity NPC472387
0.9349 High Similarity NPC293626
0.9349 High Similarity NPC476621
0.9345 High Similarity NPC472607
0.9345 High Similarity NPC81042
0.9345 High Similarity NPC473327
0.9345 High Similarity NPC476472

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC211532 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9817 High Similarity NPD4338 Clinical (unspecified phase)
0.9341 High Similarity NPD6797 Phase 2
0.9337 High Similarity NPD7054 Approved
0.9286 High Similarity NPD7251 Discontinued
0.9281 High Similarity NPD7472 Approved
0.9231 High Similarity NPD7808 Phase 3
0.9167 High Similarity NPD7074 Phase 3
0.9162 High Similarity NPD3818 Discontinued
0.8957 High Similarity NPD2801 Approved
0.8929 High Similarity NPD6167 Clinical (unspecified phase)
0.8929 High Similarity NPD6166 Phase 2
0.8929 High Similarity NPD6168 Clinical (unspecified phase)
0.8909 High Similarity NPD4381 Clinical (unspecified phase)
0.8902 High Similarity NPD3817 Phase 2
0.878 High Similarity NPD1934 Approved
0.8772 High Similarity NPD7804 Clinical (unspecified phase)
0.8675 High Similarity NPD5402 Approved
0.8623 High Similarity NPD4868 Clinical (unspecified phase)
0.8623 High Similarity NPD3882 Suspended
0.8614 High Similarity NPD2393 Clinical (unspecified phase)
0.8528 High Similarity NPD1512 Approved
0.8462 Intermediate Similarity NPD7075 Discontinued
0.8457 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8424 Intermediate Similarity NPD1653 Approved
0.8405 Intermediate Similarity NPD1511 Approved
0.8363 Intermediate Similarity NPD5494 Approved
0.8333 Intermediate Similarity NPD6801 Discontinued
0.8323 Intermediate Similarity NPD4380 Phase 2
0.8305 Intermediate Similarity NPD6559 Discontinued
0.8297 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD5403 Approved
0.8239 Intermediate Similarity NPD5844 Phase 1
0.8202 Intermediate Similarity NPD7685 Pre-registration
0.8182 Intermediate Similarity NPD6799 Approved
0.8133 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD5401 Approved
0.8125 Intermediate Similarity NPD7473 Discontinued
0.8122 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD7228 Approved
0.807 Intermediate Similarity NPD1465 Phase 2
0.8057 Intermediate Similarity NPD6232 Discontinued
0.8011 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7199 Phase 2
0.7989 Intermediate Similarity NPD6234 Discontinued
0.7989 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7978 Intermediate Similarity NPD3751 Discontinued
0.7965 Intermediate Similarity NPD7819 Suspended
0.7955 Intermediate Similarity NPD3787 Discontinued
0.7953 Intermediate Similarity NPD7411 Suspended
0.7929 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7912 Intermediate Similarity NPD8312 Approved
0.7912 Intermediate Similarity NPD8313 Approved
0.7907 Intermediate Similarity NPD37 Approved
0.7895 Intermediate Similarity NPD6599 Discontinued
0.7879 Intermediate Similarity NPD1549 Phase 2
0.7874 Intermediate Similarity NPD4967 Phase 2
0.7874 Intermediate Similarity NPD4966 Approved
0.7874 Intermediate Similarity NPD4965 Approved
0.7865 Intermediate Similarity NPD7435 Discontinued
0.7844 Intermediate Similarity NPD6190 Approved
0.7801 Intermediate Similarity NPD6781 Approved
0.7801 Intermediate Similarity NPD6782 Approved
0.7801 Intermediate Similarity NPD6778 Approved
0.7801 Intermediate Similarity NPD6777 Approved
0.7801 Intermediate Similarity NPD6779 Approved
0.7801 Intermediate Similarity NPD6780 Approved
0.7801 Intermediate Similarity NPD6776 Approved
0.7797 Intermediate Similarity NPD1247 Approved
0.7784 Intermediate Similarity NPD919 Approved
0.7784 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD2796 Approved
0.7711 Intermediate Similarity NPD7266 Discontinued
0.7706 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD6959 Discontinued
0.7697 Intermediate Similarity NPD1510 Phase 2
0.7667 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7626 Intermediate Similarity NPD7874 Approved
0.7626 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD230 Phase 1
0.7622 Intermediate Similarity NPD1933 Approved
0.7611 Intermediate Similarity NPD3926 Phase 2
0.7609 Intermediate Similarity NPD7240 Approved
0.759 Intermediate Similarity NPD7696 Phase 3
0.759 Intermediate Similarity NPD7698 Approved
0.759 Intermediate Similarity NPD7697 Approved
0.7588 Intermediate Similarity NPD7783 Phase 2
0.7588 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD8151 Discontinued
0.7574 Intermediate Similarity NPD3750 Approved
0.7561 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1613 Approved
0.7551 Intermediate Similarity NPD7871 Phase 2
0.7551 Intermediate Similarity NPD7870 Phase 2
0.7545 Intermediate Similarity NPD2935 Discontinued
0.7539 Intermediate Similarity NPD6534 Approved
0.7539 Intermediate Similarity NPD6535 Approved
0.7528 Intermediate Similarity NPD3749 Approved
0.7525 Intermediate Similarity NPD7701 Phase 2
0.7515 Intermediate Similarity NPD447 Suspended
0.75 Intermediate Similarity NPD8434 Phase 2
0.75 Intermediate Similarity NPD7801 Approved
0.75 Intermediate Similarity NPD8150 Discontinued
0.7475 Intermediate Similarity NPD7584 Approved
0.7472 Intermediate Similarity NPD7768 Phase 2
0.7471 Intermediate Similarity NPD4628 Phase 3
0.7461 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD8455 Phase 2
0.7455 Intermediate Similarity NPD1240 Approved
0.7455 Intermediate Similarity NPD943 Approved
0.744 Intermediate Similarity NPD1551 Phase 2
0.7439 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD7699 Phase 2
0.7423 Intermediate Similarity NPD7700 Phase 2
0.7399 Intermediate Similarity NPD2533 Approved
0.7399 Intermediate Similarity NPD2532 Approved
0.7399 Intermediate Similarity NPD2534 Approved
0.7378 Intermediate Similarity NPD3027 Phase 3
0.7374 Intermediate Similarity NPD8320 Phase 1
0.7374 Intermediate Similarity NPD8319 Approved
0.7365 Intermediate Similarity NPD1607 Approved
0.736 Intermediate Similarity NPD6823 Phase 2
0.7317 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD920 Approved
0.731 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD6233 Phase 2
0.7278 Intermediate Similarity NPD3748 Approved
0.7278 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD5953 Discontinued
0.7264 Intermediate Similarity NPD7585 Approved
0.726 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD7680 Approved
0.7232 Intermediate Similarity NPD3226 Approved
0.7232 Intermediate Similarity NPD7458 Discontinued
0.7222 Intermediate Similarity NPD5353 Approved
0.7214 Intermediate Similarity NPD7583 Approved
0.7207 Intermediate Similarity NPD6844 Discontinued
0.72 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD2799 Discontinued
0.7176 Intermediate Similarity NPD7033 Discontinued
0.7172 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD7286 Phase 2
0.7128 Intermediate Similarity NPD6213 Phase 3
0.7128 Intermediate Similarity NPD6212 Phase 3
0.7128 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD2313 Discontinued
0.7126 Intermediate Similarity NPD6798 Discontinued
0.711 Intermediate Similarity NPD1243 Approved
0.711 Intermediate Similarity NPD6674 Discontinued
0.711 Intermediate Similarity NPD1652 Phase 2
0.711 Intermediate Similarity NPD2800 Approved
0.7108 Intermediate Similarity NPD6832 Phase 2
0.7105 Intermediate Similarity NPD7549 Discontinued
0.7105 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD6355 Discontinued
0.7101 Intermediate Similarity NPD5124 Phase 1
0.7101 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD2346 Discontinued
0.7092 Intermediate Similarity NPD4360 Phase 2
0.7092 Intermediate Similarity NPD4363 Phase 3
0.7086 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD9494 Approved
0.7043 Intermediate Similarity NPD5242 Approved
0.7039 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD6100 Approved
0.7035 Intermediate Similarity NPD6099 Approved
0.7031 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD1203 Approved
0.7027 Intermediate Similarity NPD8127 Discontinued
0.7024 Intermediate Similarity NPD3268 Approved
0.7015 Intermediate Similarity NPD5005 Approved
0.7015 Intermediate Similarity NPD5006 Approved
0.7006 Intermediate Similarity NPD4908 Phase 1
0.7 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.6995 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6994 Remote Similarity NPD1091 Approved
0.6989 Remote Similarity NPD5711 Approved
0.6989 Remote Similarity NPD5710 Approved
0.6988 Remote Similarity NPD2798 Approved
0.6971 Remote Similarity NPD7930 Approved
0.6961 Remote Similarity NPD6386 Approved
0.6961 Remote Similarity NPD6385 Approved
0.6959 Remote Similarity NPD6651 Approved
0.6951 Remote Similarity NPD9269 Phase 2
0.6941 Remote Similarity NPD4060 Phase 1
0.6928 Remote Similarity NPD2797 Approved
0.6923 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6919 Remote Similarity NPD7097 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data